Lv2
196 积分 2023-03-25 加入
Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study
1天前
求助中
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease
1个月前
已完结
A Risk Stratification Tool for Relapse After Intravenous-To-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases
1个月前
已完结
Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow-Up
2个月前
已完结
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
2个月前
已关闭
Effectiveness and Safety of Tofacitinib in Biologic-Naïve Elderly Patients with Ulcerative Colitis
3个月前
已关闭
Risk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study
3个月前
已完结
Risk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study
3个月前
已完结
Fibrosis in IBD: from pathogenesis to therapeutic targets
4个月前
已完结
Fecal Calprotectin Correlates with Disease Extent but Remains a Reliable Marker of Mucosal Healing in Ulcerative Colitis
4个月前
已完结
皖公网安备34019202002308
